CSIMarket
Company Name or Ticker Symbol
Search for oher Categories
 



<< Back to Financial Strength by Company within Biotechnology & Drugs Industry

Biotechnology & Drugs Industry Financial Strength Information

Financial Strength Information & Trends    
 
Select the Industry: Select the Category: Select the Period:

Biotechnology & Drugs Industry 1 Q 4 Q 3 Q 2 Q 1 Q
  2017 2016 2016 2016 2016
Quick Ratio (TTM) 1.66 1.62 2.22 4.02 3.93
Quick Ratio Ranking # 9 # 8 # 4 # 1 # 1
Working Capital Ratio (TTM) 2.53 2.52 3.1 4.94 4.98
Working Capital Ratio Ranking # 14 # 13 # 4 # 2 # 2
Working Capital Per Revenue 0.62 0.6 0.79 1.5 1.35
Working Capital Per Revenue Ranking # 95 # 95 # 97 # 98 # 98
Leverage Ratio (TTM) 1.42 1.42 2.16 0.71 0.74
Leverage Ratio Ranking # 33 # 34 # 56 # 10 # 10
Total Debt to Equity (TTM) 0.06 0.06 0.09 0.01 0.02
Total Debt to Equity Ranking # 56 # 48 # 69 # 17 # 17
Interest Coverage (TTM) 17.67 18.54 - - -
Interest Coverage Ranking # 20 # 18 # 103 # 96 # 97
Debt Coverage (TTM) 4.36 4.82 4.61 - -
Debt Coverage Ranking # 58 # 48 # 54 # 100 # 99


Quick Ratio Comment
On the trailing twelve months basis Biotechnology & Drugs Industry's Cash & cash equivalent grew by 0.83 % in 1 Q 2017 sequentially, faster than Current Liabilities, this led to improvement in Biotechnology & Drugs Industry's Quick Ratio to 1.66 , above Biotechnology & Drugs Industry average Quick Ratio.



Within Healthcare sector, Biotechnology & Drugs Industry achieved highest Quick Ratio. Quick Ratio total ranking has deteriorated compare to the previous quarter from to 9.

Note, first quarter Numbers include only companies who have reported first quarter earnings results. Numbers change as more businesses report financial results. See the full List.

Quick Ratio Statistics
High Average Low
4.02 1.53 1.07
2. quarter 2016   1. quarter 2011

Quick Ratio Industry Ranking
Within: No.
Sector # 1
S&P 500 # 9

You need to upgrade your Flash Player

Other Quick Ratios
Compare Industry's quick ratio to Btcy's or S&P Constituent list of Biotechnology & Drugs Industry
Highest Ranking Quick Ratios Lowest Ranking Quick Ratios
Quick Ratios for BTCY's Competitors Definiton of Quick Ratio


Biotechnology & Drugs Industry Working Capital Ratio Statistics
 

You need to upgrade your Flash Player


Working Capital Ratio Statistics
High Average Low
4.98 2.7 2.2
1. quarter 2016   1. quarter 2011



Working Capital Ratio Comment
On the trailing twelve months basis Current Liabilities decreased faster than Industry's Current Assets, this led to improvement in Industry's Working Capital Ratio to 2.53 , Working Capital Ratio remained below Biotechnology & Drugs Industry average.



Within Healthcare sector only one Industry has achieved higher Working Capital Ratio. Working Capital Ratio total ranking has deteriorated compare to the previous quarter from to 14.



Working Capital Ratio Industry Ranking
Within: No.
Sector # 2
S&P 500 # 14

Other Working Capital Ratios
Highest Ranking Working Capital Ratios Lowest Ranking Working Capital Ratios
Compare Industry's Working Capital ratio to Btcy's or S&P Constituent list of Biotechnology & Drugs Industry
Working Capital ratios for BTCY's Competitors Definiton of Working Capital Ratio

Biotechnology & Drugs Industry Working Capital Per Revenue Statistics
 
Working Capital Per Revenue Comment
On the trailing twelve months basis Biotechnology & Drugs Industry's Working Capital Per Revenue sequentially grew to 0.62, above Industry average. Due to decline in revenue year on year by -3.78%.



Within Healthcare sector 5 other industries have achieved lower Working Capital Per Revenue. Working Capital Per Revenue total ranking has deteriorated compare to the previous quarter from to 95.


Working Capital Per Revenue Statistics
High Average Low
1.5 0.55 0.42
2. quarter 2016   1. quarter 2005


Working Capital Per Revenue Industry Ranking
Within: No.
Sector # 6
S&P 500 # 95
You need to upgrade your Flash Player



Other Working Capital Per Revenue
Compare Industry's Working Capital Per Revenue to Btcy's or S&P Constituent list of Biotechnology & Drugs Industry
Return On Assets for Biotechnology & Drugs Industry Definiton of Working Capital Per Revenue



Biotechnology & Drugs Industry Leverage Ratio Statistics
 
You need to upgrade your Flash Player
Leverage Ratio Statistics
High Average Low
2.16 0.84 0.4
3. quarter 2016   4. quarter 2004



Leverage Ratio Comment
Despite net new borrowings of 1.12% Industry managed to improve Liabilities to Equity ratio in 1 Q 2017 to 1.42, above Biotechnology & Drugs Industry average.



Among other Industries in the Healthcare sector 3 other industries have achieved lower Leverage Ratio.



Leverage Ratio overall ranking has deteriorated compare to the previous quarter from to 33.



Leverage Ratio Industry Ranking
Within: No.
Sector # 4
S&P 500 # 33

Other Leverage Ratios
Compare Industry's Leverage ratio to Btcy's or S&P Bond Interest rates
Highest Ranking Leverage Ratios Lowest Ranking Leverage Ratios
Leverage Ratios for BTCY's Competitors What is Leverage Ratio?


Biotechnology & Drugs Industry Total Debt to Equity Ratio Statistics
 
Debt to Equity Ratio Comment
Despite net new borrowings of 6.57% Industry managed to improve Total Debt to Equity in 1 Q 2017 to 0.06, below Industry average.



Within Healthcare sector 4 other industries have achieved lower Debt to Equity Ratio. Debt to Equity Ratio total ranking has deteriorated compare to the previous quarter from to 56.



Debt to Equity Ratio Statistics
High Average Low
0.96 0.43 0.01
3. quarter 2014  



Debt to Equity Industry Ranking
Within: No.
Sector # 5
S&P 500 # 56
You need to upgrade your Flash Player

Other Debt to Equity Ratios
Highest Ranking Debt to Equity Ratios Lowest Ranking Debt to Equity Ratios
Compare Industry's Debt to Equity ratio to Btcy's or S&P Definiton of Debt to Equity Ratio

Biotechnology & Drugs Industry Interest Coverage Ratio Statistics
 
You need to upgrade your Flash Player
Interest Coverage Ratio Statistics
High Average Low
980.14 42.51 -319.42
4. quarter 2004  

Interest Coverage Ratio Comment
On the trailing twelve months basis Due to increase in interest expenses in 1 Q 2017, Interest Coverage Ratio fell to 17.67 below Biotechnology & Drugs Industry average.



In the Healthcare sector, Biotechnology & Drugs Industry achieved highest Interest Coverage Ratio. Interest Coverage overall ranking has deteriorated compare to the previous quarter from to 20.



Interest Coverage Ratio Industry Ranking
Within: No.
Sector # 1
S&P 500 # 20

Other Interest Coverage Ratios
Highest Ranking Interest Coverage Ratios Lowest Ranking Interest Coverage Ratios
Compare Industry's Interest Coverage ratio to Btcy's or S&P Definiton of Interest Coverage Ratio

Biotechnology & Drugs Industry Debt Coverage Statistics
 
Debt Coverage Ratio Comment
On the trailing twelve months basis Due to increase in total debt in 1 Q 2017, Debt Coverage Ratio fell to 4.36 above Biotechnology & Drugs Industry average.



Looking into Healthcare sector 3 other industries have achieved higher Debt Coverage Ratio. Debt Coverage Ratio total ranking has deteriorated compare to the previous quarter from to 58.



Debt Coverage Statistics
High Average Low
4.82 0.44 -8.95
4. quarter 2016   2. quarter 2016



Debt Coverage Industry Ranking
Within: No.
Sector # 4
S&P 500 # 58
You need to upgrade your Flash Player

Other Debt Coverage Ratios
Highest Ranking Debt Coverage Ratios Lowest Ranking Debt Coverage Ratios
See also Biotechnology & Drugs Industry's Margin Definiton of Debt Coverage Ratio



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com